Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.40 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.40 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.40 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL422713 | 0.82 | LMNA (0.62) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL424085 | 0.80 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL421573 | 0.80 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL2138647 | 0.80 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL336544 | 0.80 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL10032088 | 0.80 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL14666520 | 0.80 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL14666437 | 0.80 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL10021524 | 0.80 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL29929103 | 0.80 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090198075-A1 | SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES | CHEVRON U.S.A. INC. (US) | 2009-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090198075-A1 | SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES | ELOVL5, ELOVL1, ELOVL3 | LMNA 4543/4885MAPT 1348/4885MAPK1 3988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.